Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
Eli Lilly and Company
BeOne Medicines
ViroMissile, Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
Leiden University Medical Center
Clasp Therapeutics, Inc.
Angiex, Inc.
Poseida Therapeutics, Inc.
IDEAYA Biosciences
Baylor College of Medicine
MacroGenics
Avacta Life Sciences Ltd
Oscotec Inc.
OncoNano Medicine, Inc.
MOMA Therapeutics
GlaxoSmithKline
AstraZeneca
National Cancer Institute (NCI)
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Exelixis
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Novita Pharmaceuticals, Inc.
University of Virginia
Eli Lilly and Company
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
German Cancer Research Center
Columbia University
Tomsk National Research Medical Center of the Russian Academy of Sciences
Orion Biotechnology Polska Sp. z o.o.
Daiichi Sankyo
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Astellas Pharma Inc
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Optimal Health Research
Danatlas Pharmaceuticals Co., Ltd
Pfizer
Pfizer
DNAtrix, Inc.
NGM Biopharmaceuticals, Inc